Cytokine Signalling Forum
Rheumatology Author Dr Stanley Cohen: Fenebrutinib
- Autore: Vários
- Narratore: Vários
- Editore: Podcast
- Durata: 0:12:23
- Altre informazioni
Informações:
Trama
Dr Stanley Cohen from Southwestern Medical School. Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Dr Stanley Cohen discusses a phase 2 trial of BTK inhibitor, fenebrutinib.
